Drug profile · INN
tazemetostat hydrobromide
TAZVERIK
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tazemetostat hydrobromide (TAZVERIK) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN tazemetostat hydrobromide
Brand TAZVERIK
Route ORAL
Formulation TABLET
Frequently asked questions
What is tazemetostat hydrobromide?
tazemetostat hydrobromide (TAZVERIK) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tazemetostat hydrobromide?
TAZVERIK is a marketed brand name for tazemetostat hydrobromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tazemetostat hydrobromide?
tazemetostat hydrobromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.